Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Unite to acquire Empiric Student Property in £723m deal

(Sharecast News) - Student accommodation firm Unite Group said on Thursday that it has agreed to acquire rival Empiric Student Property in a cash-and-share deal that will reshape Britain's student accommodation landscape. The acquisition will bring together two of the sector's most prominent players, with Unite aiming to expand its reach into the postgraduate and returner student market segments, where Empiric has a strong foothold.

The £723m transaction will see Empiric shareholders receive 0.085 new Unite shares and 32p in cash per share, valuing Empiric at a 24% premium to its six-month average.

Unite said the combined portfolio will grow to £10.5bn, with approximately 75,000 beds across key university cities, including 92% in Russell Group locations.

Unite expects the acquisition to deliver £13.7m in annual cost synergies, supporting earnings and dividend accretion. Empiric shareholders will retain a 10% stake in the enlarged group.

The transaction, which will be subject to shareholder and court approval, was expected to be completed in Q226.

As of 0820 BST, Empiric shares were down 2.46% at 91.30p, while Unite shares were up 0.068% at 732.50p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.